Our results demonstrate that an increase in cytoplasmic HA through overexpression of HAS1 in different human cell types increases the characteristic cancer phenotypes of clonal variation, EMT, micronucleation and centrosome abnormalities such as clustering and/or fragmentation. This evidence concerns the gene HAS1 and cancer.